itraconazole has been researched along with Athlete's Foot in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.94) | 18.7374 |
| 1990's | 18 (52.94) | 18.2507 |
| 2000's | 7 (20.59) | 29.6817 |
| 2010's | 7 (20.59) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Carreira, A; Ferreira, J; Ferreira, JB; Ferreira, RB; Filipe, P; Monteiro, S; Pereira, I | 1 |
| Cabrera, R; Sabatin, N; Sepúlveda, R; Urrutia, M | 1 |
| Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA | 1 |
| Goindi, S; Kumar, N | 1 |
| Kumar, N | 1 |
| Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
| Balta, I; Oz, A; Oz, Y; Qoraan, I | 1 |
| Kawana, S; Kikuchi, I; Kusunoki, T; Morimoto, K; Tanuma, H | 1 |
| Chaichalotornkul, J; Hoharitanon, S; Sindhupak, W | 1 |
| Fimiani, M; Ghilardi, A; Romano, C; Rubegni, P | 1 |
| Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ; Millan-Chiu, B; Mondragón-González, R; Velásquez-Hernández, V | 1 |
| Decroix, J | 1 |
| Clayton, YM; Hay, RJ; McGregor, JM; Ryatt, KS; Wuite, J; Ziegler, C | 1 |
| Ali, KB; Goh, CL; Koh, MT; Seow, CS; Tay, YK | 1 |
| Wishart, JM | 1 |
| De Backer, M; De Keyser, P; Massart, DL; Westelinck, KJ | 1 |
| Bräutigam, M; Nolting, S; Schopf, RE; Weidinger, G | 1 |
| Brodell, RT | 1 |
| Del Rosso, JQ | 1 |
| Decroix, J; Degreef, H; Doncker, PD; Gupta, AK; Heenen, M; Heremans, A; Piérard, GE; Stoffels, P | 1 |
| Doncker, PD; Gupta, AK; Heremans, A; Marynissen, G; Stoffels, P | 1 |
| Scher, RK; Seeburger, J | 1 |
| Baran, E; Decroix, J; Del Palacio, A; Gwiezdzinski, Z; Levy, G; Tausch, I; Urbanowski, S; Ziarkiewicz, M | 1 |
| Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
| Avnstorp, C; Heremans, A; Nilsson, J; Svejgaard, E; Wanscher, B | 1 |
| Rampen, FH; Remme, JJ; Schuller, J; Van Neer, FC | 1 |
| De Doncker, P; Gupta, AK | 1 |
| De Doncker, P | 1 |
| De Doncker, P; de Prost, Y; Degreef, H; Delescluse, J; Gupta, AK; Marynissen, G; Nolting, S; Theissen, U; Wallace, R | 1 |
| Brodell, RT; Elewski, B | 1 |
| Haustein, UF; Manz, B; Mittag, M; Nenoff, P; Rytter, M | 1 |
| Fukai, K; Ishii, M; Kobayashi, H; Mizuno, N; Morimoto, K; Nakanishi, T | 1 |
| Van Cutsem, J; Van Hecke, E | 1 |
5 review(s) available for itraconazole and Athlete's Foot
| Article | Year |
|---|---|
What is new in fungal pharmacotherapeutics?
Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles | 2014 |
Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Tinea Pedis | 1996 |
Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
Topics: Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Drug Monitoring; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis; Remission Induction; Safety; Tinea; Tinea Pedis | 1997 |
Itraconazole and terbinafine in perspective. From petri dish to patient.
Topics: Administration, Oral; Animals; Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Itraconazole and terbinafine in perspective: from petri dish to patient.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Foot Dermatoses; Humans; In Vitro Techniques; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
11 trial(s) available for itraconazole and Athlete's Foot
| Article | Year |
|---|---|
A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
Topics: Adult; Antifungal Agents; Drugs, Generic; Female; Humans; Itraconazole; Male; Middle Aged; Tinea Pedis; Treatment Outcome | 2005 |
Tinea pedis (mocassin-type) treated with itraconazole.
Topics: Administration, Oral; Adult; Female; Humans; Itraconazole; Male; Middle Aged; Tinea Pedis; Treatment Outcome | 1995 |
A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Terbinafine; Tinea Pedis; Treatment Outcome | 1995 |
A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
Topics: Adult; Double-Blind Method; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Tinea; Tinea Pedis; Treatment Outcome | 1994 |
Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study.
Topics: Administration, Oral; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Naphthalenes; Terbinafine; Tinea Pedis | 1994 |
German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Satisfaction; Terbinafine; Tinea Pedis | 1996 |
Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
Topics: Antifungal Agents; Double-Blind Method; Follow-Up Studies; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea; Tinea Pedis; Treatment Outcome | 1998 |
Efficacy and safety of short-term itraconazole in tinea pedis: a double-blind, randomized, placebo-controlled trial.
Topics: Abdominal Pain; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Male; Patient Dropouts; Placebos; Time Factors; Tinea Pedis; Treatment Outcome | 1998 |
Itraconazole in the treatment of tinea pedis and tinea manuum: comparison of two treatment schedules.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Tinea; Tinea Pedis; Treatment Outcome | 1998 |
The use of itraconazole to treat cutaneous fungal infections in children.
Topics: Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Dose-Response Relationship, Drug; Drug Eruptions; Follow-Up Studies; Foot Dermatoses; Gastritis; Headache; Humans; Infant; Itraconazole; Microsporum; Onychomycosis; Patient Dropouts; Skin; Time Factors; Tinea; Tinea Capitis; Tinea Pedis; Treatment Outcome; Trichophyton | 1999 |
Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea; Tinea Pedis | 1988 |
18 other study(ies) available for itraconazole and Athlete's Foot
| Article | Year |
|---|---|
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Topics: Antifungal Agents; Arthrodermataceae; Crop Protection; Drug Discovery; Fluconazole; Fungicides, Industrial; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Tinea Pedis; Tinea Versicolor; Trichophyton | 2018 |
[Tinea nigra: a allochthonous case report in Chile].
Topics: Adult; Antifungal Agents; Female; Humans; Itraconazole; Tinea Pedis | 2013 |
Statistically designed nonionic surfactant vesicles for dermal delivery of itraconazole: characterization and in vivo evaluation using a standardized Tinea pedis infection model.
Topics: Administration, Cutaneous; Animals; Antifungal Agents; Cholesterol; Colony Count, Microbial; Disease Models, Animal; Drug Design; Female; Hexoses; Itraconazole; Oxidative Stress; Rats, Wistar; Skin; Skin Absorption; Surface-Active Agents; Tinea Pedis | 2014 |
D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Topics: Administration, Topical; Animals; Antifungal Agents; Catalase; Drug Design; Emulsions; Female; Glutathione; Hydrogen-Ion Concentration; Itraconazole; L-Lactate Dehydrogenase; Lipids; Rats, Wistar; Rheology; Skin; Surface-Active Agents; Tinea Pedis; Treatment Outcome; Trichophyton | 2015 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluconazole; Glycated Hemoglobin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Prevalence; Sex Factors; Terbinafine; Tinea Pedis; Toes; Trichophyton; Turkey | 2017 |
Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Topics: Administration, Oral; Adult; Antifungal Agents; Epidermis; Female; Humans; Itraconazole; Male; Middle Aged; Tinea Pedis; Treatment Outcome | 2004 |
A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
Topics: Adult; Antifungal Agents; Blister; Dermatomycoses; Female; Humans; Imidazoles; Itraconazole; Tinea Pedis; Trichophyton | 2006 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Epidermophyton; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Mexico; Microsporum; Onychomycosis; Tinea; Tinea Capitis; Tinea Pedis; Trichophyton | 2007 |
In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Epidermophyton; Female; Griseofulvin; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Singapore; Tinea; Tinea Pedis; Trichophyton | 1994 |
Ethics and micromanaged care.
Topics: Antifungal Agents; Dermatology; Disclosure; Ethics, Medical; Foot Dermatoses; Humans; Itraconazole; Male; Managed Care Programs; Middle Aged; Onychomycosis; Risk Assessment; Tinea Pedis; United States | 1996 |
Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Middle Aged; Tinea Pedis | 1997 |
Long-term remission of two feet-one hand syndrome.
Topics: Adult; Antifungal Agents; Hand Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Syndrome; Tinea Pedis; Trichophyton | 1998 |
Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Topics: Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Recurrence; Terbinafine; Time Factors; Tinea; Tinea Pedis; Toes; Trichophyton | 1998 |
Antifungal drug interactions. Avoidance requires more than memorization.
Topics: Antifungal Agents; Cardiotonic Agents; Digoxin; Drug Interactions; Humans; Itraconazole; Male; Middle Aged; Nail Diseases; Tinea Pedis | 2000 |
[Painful swelling of the foot of a 16-year-old African. Eumycetoma (Madura foot)].
Topics: Adolescent; Antifungal Agents; Diagnosis, Differential; Humans; Itraconazole; Male; Mycetoma; Time Factors; Tinea Pedis; Trichophyton | 2001 |
[Monthly cycles of 1-week therapy with itraconazole for patients with Tinea pedis].
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Pulse Therapy, Drug; Quality of Life; Surveys and Questionnaires; Tinea Pedis | 2002 |